Back to News
Market Impact: 0.1
Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
Source: GlobeNewswire
Healthcare & Biotech
Moleculin Biotech announced that it will present at the 2026 Maxim Growth Summit in New York. The article provides no presentation date, financial updates, or other material details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Profound Medical stock surges 20% on raised Q3 revenue outlook
- Medical device maker Centinel Spine discloses revenue rise in US IPO filing
- Halozyme stock rises after winning injunction against Merck
- BTIG cuts ArriVent BioPharma stock price target on trial results
- MustGrow Biologics at 20th iif: sales grow as Bayer backs pipeline
- AVBP SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving ArriVent BioPharma